Globe Life Inc. (GL) AI Stock Analysis

Globe Life Inc., originally incorporated as Torchmark Corporation in 1979, provides insurance solutions primarily to lower middle to middle-income households across the United States. Headquartered in McKinney, Texas, the company operates across four main segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. Its product offerings include whole life and term life policies, Medicare supplement plans, critical illness and accident coverage, as well as single-premium and flexible-premium deferred annuities. Employing 3,695 people, the firm focuses on delivering affordable and accessible protection products tailored to meet the unique financial security needs of its target customer market.

Globe Life increased annual revenue from $5.11B in FY2021 to $6.00B in FY2025, recording a 5-year revenue CAGR of 4.8%. Net income expanded from $745.0M in FY2021 to $1.16B in FY2025, lifting EPS from $6.86 to $14.54 over the same timeframe. Annual operating margin improved from 17.8% in FY2021 to 24.4% in FY2025, while net margin reached 19.4%. Over the trailing twelve months, revenue was $6.19B with an operating margin of 24.6% and EPS of $15.07. For the latest quarter ended June 30, 2026, quarterly revenue grew 8.0% year-over-year, while quarterly earnings increased 19.7%.

As of June 30, 2026, Globe Life held $455.4M in cash and short-term investments against $2.94B in total debt, resulting in net debt of $2.49B. Total assets stood at $31.56B compared to shareholders' equity of $6.16B, resulting in a debt-to-equity ratio of 0.48 and a current ratio of 1.41. In FY2025, operating cash flow reached $1.40B and free cash flow was $1.25B. Capital expenditures totaled $142.5M, while the company returned capital through $881.0M in share buybacks and $86.1M in dividends paid.

Globe Life has a market capitalization of $12.97B and an enterprise value of $15.65B. The stock trades at a trailing P/E of 11.2x and a forward P/E of 10.2x, both below the median of its S&P 500 Financial Services peers of 14.2x and 12.6x, respectively. Its price-to-sales multiple is 2.1x versus the peer median of 3.1x, and its PEG ratio is 1.30. Over the past year, the stock returned 27.3%, outperforming the S&P 500 return of 16.8%, while its 5-year return of 80.6% tracks just below the index return of 83.0%.

Globe Life pays an annualized forward dividend of $1.32 per share, reflecting a dividend yield of 0.78% and a modest payout ratio of 8.3%. The company has paid consecutive dividends for 41 years, achieving a 5-year annualized dividend growth rate of 7.3%. Its quarterly dividend had a last ex-dividend date of October 5, 2026.

Wall Street coverage consists of 4 Strong Buy, 4 Buy, and 3 Hold ratings, with no Sell or Strong Sell recommendations. The mean price target is $193.18, representing an upside of 14.5% from the last close of $168.77. For the fiscal year ending December 31, 2026, consensus estimates project EPS of $15.70, up 8.2%, and revenue of $6.39B. Analysts have seen 1 EPS beat in the last 4 quarters, and the next earnings date is October 21, 2026.

This page is an AI-written research summary of Globe Life Inc. (GL). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: GL income statement, GL balance sheet, GL key metrics, GL analyst forecast, GL chart. See the GL stock overview for the latest quote and news.